Fungal endophthalmitis in intravenous drug users injecting buprenorphine contaminated with oral Candida species

Aboltins, Craig A; Daffy, John R; Allen, Penny

doi:10.5694/j.1326-5377.2005.tb06764.x

Topics

Substance‐related disorders

Infectious diseases

Eye diseases

Craig A Aboltins,* John R Daffy,^† Penny Allen^‡

1 St Vincent’s Hospital, Victoria Parade, Fitzroy, VIC 3065
2 Royal Victorian Eye and Ear Hospital, East Melbourne, VIC.

Correspondence: craigaboltins@netspace.net.au

Acknowledgements:

We thank Dr Adam Jenney for his very helpful editing, Miss Rowena Fary for advice about buprenorphine dispensing and Dr C H Khong for assisting with clinical information about the patients.

1. Essman TF, Flynn HF, Smiddy WE, et al. Treatment outcomes in a 10-year study of fungal endophthalmitis. Ophthalmic Surg Lasers 1997; 28: 185-194.
2. Newton-John HF, Wise K, Looke DF. Role of the lemon in disseminated candidiasis of heroin abusers. Med J Aust 1984; 140: 780-781.
3. Cassoux N, Bodaghi B, Lenoang P, Edel Y. Presumed ocular candidiasis in drug misusers after intravenous use of oral high dose buprenorphine (Subutex). Br J Ophthalmol 2002; 86: 940-941.

Online responses are no longer available. Please refer to our instructions for authors page for more information.